Cargando…

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19

INTRODUCTION: Management of the COVID-19 pandemic is hampered by long delays associated with centralised laboratory PCR testing. In hospitals this leads to poor patient flow and nosocomial transmission and so rapid, accurate diagnostic tests are urgently required. The FebriDx is a point-of-care test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Tristan W., Brendish, Nathan J, Poole, Stephen, Naidu, Vasanth V., Mansbridge, Christopher, Norton, Nicholas, Wheeler, Helen, Presland, Laura, Ewings, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306108/ https://www.ncbi.nlm.nih.gov/pubmed/32579983 http://dx.doi.org/10.1016/j.jinf.2020.06.051

Ejemplares similares

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department – ADDENDUM
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study
por: Brendish, Nathan J., et al.
Publicado: (2022)

Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections
por: Self, Wesley H., et al.
Publicado: (2017)

FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis
por: Lippi, G., et al.
Publicado: (2022)

Utility of the FebriDx point‐of‐care test for rapid triage and identification of possible coronavirus disease 2019 (COVID‐19)
por: Karim, Nawazish, et al.
Publicado: (2020)

415. Clinical Impact of Molecular Point-of-Care Testing for COVID-19 in Adults Presenting to Hospital: A Prospective, Interventional, Non-Randomised, Controlled Study
por: Brendish, Nathan J, et al.
Publicado: (2020)

FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019)

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
por: Brendish, Nathan J, et al.
Publicado: (2020)

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study
por: Buntine, Paul, et al.
Publicado: (2022)

Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study
por: Houston, Hamish, et al.
Publicado: (2021)

Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection
por: Brendish, Nathan J, et al.
Publicado: (2020)

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
por: Dick, Katherine, et al.
Publicado: (2021)

2023. A Prospective, Multi-Center U.S. Clinical Trial to Determine Accuracy of FebriDx Point-of-Care Testing for Acute Upper Respiratory Infections with and Without a Confirmed Fever
por: Sambursky, Robert, et al.
Publicado: (2018)

1034. FebriDx use in Immunocompromised Patients in a Real-World Hospital Setting during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

654. Evaluation of the Febridx Host Response Point-of-Care Test to Differentiate Viral From Bacterial Etiology in Adults Hospitalized with Acute Respiratory Illness During Influenza Season
por: Beard, Kate, et al.
Publicado: (2019)

120. Impact of a Molecular Point-of-care ‘test and Treat’ Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC)
por: Clark, Tristan William, et al.
Publicado: (2020)

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial
por: Clark, Tristan W, et al.
Publicado: (2021)

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease
por: Brendish, Nathan J., et al.
Publicado: (2019)

Febris Nigra—“Black Death”
Publicado: (1866)

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)

On the Cure of the Febris Intermittens, by the Ammonia Preparata
por: Rainbird, Philip
Publicado: (1806)

On the Recent Outbreak of “Febris Nigra” in Dublin
por: Lyons, Robert D.
Publicado: (1868)

1717. The Impact of Routine Molecular Point-of-care Testing for Gastrointestinal Pathogens in Adults Hospitalized With Suspected Gastroenteritis: Results of a Pragmatic Randomized Controlled Trial (GastroPOC)
por: Malachira, Ahalya, et al.
Publicado: (2018)

Succincta Descriptio Febris Malagæ nuper sævientis
Publicado: (1805)

Historia Febris Hecticæ omnis ævi Observata Medica Continens
Publicado: (1785)

Report of Additional Cases of Febris Intermittens, Treated with the Extract Pinckneya Pubens
por: Fauntleroy, A. M.
Publicado: (1864)

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
por: Brendish, Nathan J, et al.
Publicado: (2017)

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study
por: Poole, Stephen, et al.
Publicado: (2020)

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential
por: Brendish, Nathan J., et al.
Publicado: (2015)

2796. The Impact of Syndromic Molecular Point-of-Care Testing for Respiratory Viruses on Antibiotic Use in Adults Presenting to Hospital with Exacerbation of Airways Disease: Further Analysis From a Randomized Controlled Trial
por: Clark, Tristan William, et al.
Publicado: (2019)

Accuracy of rapid point-of-care antibody test in patients with suspected or confirmed COVID-19
por: Vancheeswaran, Rama, et al.
Publicado: (2022)

Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illness
por: Clark, Tristan W., et al.
Publicado: (2016)

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19
por: Livingstone, Robert, et al.
Publicado: (2022)

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
por: Poole, Stephen, et al.
Publicado: (2020)

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)
por: Brendish, Nathan J., et al.
Publicado: (2017)

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance
por: Tanner, Alex R, et al.
Publicado: (2021)

Accuracy of the Safer Dx Instrument to Identify Diagnostic Errors in Primary Care
por: Al-Mutairi, Aymer, et al.
Publicado: (2016)

Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al
por: Brendish, N.J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s8sq5so4hgj471h607rgmqevcp